ApprovalTrail

Company · Etobicoke, Ontario, Canada

Mylan Pharmaceuticals Ulc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
608
135 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
536

Drug products

Authorized products first.

NameDINStatus
CAMPRAL02293269Marketed
CLARUS02257955Marketed
CLARUS02257963Marketed
GEN-CLOZAPINE02247243Marketed
GEN-CLOZAPINE02247244Marketed
GEN-CLOZAPINE02305003Marketed
GEN-CLOZAPINE02305011Marketed
GEN-CLOZAPINE02554631Marketed
GEN-CLOZAPINE02554658Marketed
GEN-CLOZAPINE02554666Marketed
GEN-CLOZAPINE02554674Marketed
GEN-CLOZAPINE02554682Marketed
GLATIRAMER ACETATE INJECTION02541440Marketed
MYL-ESOMEPRAZOLE02479419Marketed
MYL-ESOMEPRAZOLE02479427Marketed
MYLAN-ABACAVIR/LAMIVUDINE02450682Marketed
MYLAN-ACYCLOVIR02242463Marketed
MYLAN-ACYCLOVIR02242464Marketed
MYLAN-ACYCLOVIR02242784Marketed
MYLAN-ALMOTRIPTAN02398435Marketed
MYLAN-ALMOTRIPTAN02398443Marketed
MYLAN-AMLODIPINE02272113Marketed
MYLAN-AMLODIPINE02272121Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362759Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362767Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362775Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362783Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362791Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362805Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362813Marketed
MYLAN-AMLODIPINE/ATORVASTATIN02362821Marketed
MYLAN-ATAZANAVIR02456877Marketed
MYLAN-ATAZANAVIR02456885Marketed
MYLAN-ATAZANAVIR02456893Marketed
MYLAN-ATORVASTATIN02392933Marketed
MYLAN-ATORVASTATIN02392941Marketed
MYLAN-ATORVASTATIN02392968Marketed
MYLAN-ATORVASTATIN02392976Marketed
MYLAN-ATOVAQUONE/PROGUANIL02402165Marketed
MYLAN-AZELASTINE/FLUTICASONE02530341Marketed
MYLAN-BACLOFEN02088401Marketed
MYLAN-BACLOFEN02088398Marketed
MYLAN-BECLO AQ02172712Marketed
MYLAN-BUDESONIDE AQ02230648Marketed
MYLAN-BUDESONIDE AQ02241003Marketed
MYLAN-CILAZAPRIL02283778Marketed
MYLAN-CILAZAPRIL02283786Marketed
MYLAN-CILAZAPRIL02283794Marketed
MYLAN-CINACALCET02434539Marketed
MYLAN-CINACALCET02434547Marketed
MYLAN-CINACALCET02434555Marketed
MYLAN-CLOBETASOL CREAM02024187Marketed
MYLAN-CLOBETASOL OINTMENT02026767Marketed
MYLAN-CLOBETASOL SCALP APPLICATION02216213Marketed
MYLAN-DIVALPROEX02458926Marketed
MYLAN-DIVALPROEX02458934Marketed
MYLAN-DIVALPROEX02459019Marketed
MYLAN-EFAVIRENZ02381524Marketed
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE02461412Marketed
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL02443902Marketed
MYLAN-ESCITALOPRAM02309467Marketed
MYLAN-ESCITALOPRAM02309475Marketed
MYLAN-FINGOLIMOD02469715Marketed
MYLAN-FLUCONAZOLE02245292Marketed
MYLAN-FLUCONAZOLE02245293Marketed
MYLAN-GALANTAMINE ER02339439Marketed
MYLAN-GALANTAMINE ER02339447Marketed
MYLAN-GALANTAMINE ER02339455Marketed
MYLAN-GLICLAZIDE MR02438658Marketed
MYLAN-HYDROXYUREA02242920Marketed
MYLAN-INDAPAMIDE02153483Marketed
MYLAN-INDAPAMIDE02240067Marketed
MYLAN-LAMOTRIGINE02265494Marketed
MYLAN-LAMOTRIGINE02265508Marketed
MYLAN-LAMOTRIGINE02265516Marketed
MYLAN-LANSOPRAZOLE02353830Marketed
MYLAN-LANSOPRAZOLE02353849Marketed
MYLAN-LATANOPROST02373041Marketed
MYLAN-LATANOPROST/TIMOLOL02373068Marketed
MYLAN-MIRTAZAPINE02256096Marketed
MYLAN-MIRTAZAPINE02256118Marketed
MYLAN-MIRTAZAPINE02256126Marketed
MYLAN-NAPROXEN/ESOMEPRAZOLE MR02443449Marketed
MYLAN-NAPROXEN/ESOMEPRAZOLE MR02458608Marketed
MYLAN-NEVIRAPINE02387727Marketed
MYLAN-NIFEDIPINE EXTENDED RELEASE02321149Marketed
MYLAN-NIFEDIPINE EXTENDED RELEASE02349167Marketed
MYLAN-NITRO PATCH 0.202407442Marketed
MYLAN-NITRO PATCH 0.402407450Marketed
MYLAN-NITRO PATCH 0.602407469Marketed
MYLAN-NITRO PATCH 0.802407477Marketed
MYLAN-ONDANSETRON02297868Marketed
MYLAN-ONDANSETRON02297876Marketed
MYLAN-PANTOPRAZOLE T02408570Marketed
MYLAN-PROPAFENONE02457164Marketed
MYLAN-PROPAFENONE02457172Marketed
MYLAN-RILUZOLE02390299Marketed
MYLAN-RIVASTIGMINE PATCH 1002423421Marketed
MYLAN-RIVASTIGMINE PATCH 502423413Marketed
MYLAN-RIZATRIPTAN ODT02379198Marketed
MYLAN-RIZATRIPTAN ODT02379201Marketed
MYLAN-SUMATRIPTAN02268906Marketed
MYLAN-SUMATRIPTAN02268914Marketed
MYLAN-SUMATRIPTAN02268922Marketed
MYLAN-TADALAFIL02410621Marketed
MYLAN-TADALAFIL02410648Marketed
MYLAN-TADALAFIL02410656Marketed
MYLAN-TADALAFIL02410664Marketed
MYLAN-TENOFOVIR DISOPROXIL02452634Marketed
MYLAN-TOPIRAMATE02263351Marketed
MYLAN-TOPIRAMATE02263378Marketed
MYLAN-TOPIRAMATE02263386Marketed
MYLAN-VALACYCLOVIR02351579Marketed
MYLAN-VALACYCLOVIR02351560Marketed
MYLAN-VARDENAFIL02464209Marketed
MYLAN-VARDENAFIL02464225Marketed
MYLAN-VARDENAFIL02464233Marketed
MYLAN-VERAPAMIL SR02210347Marketed
PYRIDOXINE HYDROCHLORIDE INJECTION, USP02245215Marketed
RIMSO-5000493392Marketed
VITAMIN C02245214Marketed
VTRS-ELETRIPTAN02342235Marketed
VTRS-ELETRIPTAN02342243Marketed
WIXELA INHUB02495597Marketed
WIXELA INHUB02495600Marketed
WIXELA INHUB02495619Marketed
MYLAN-FLUCONAZOLE02245697Dormant
MYLAN-GLICLAZIDE MR02449765Approved
MYLAN-LANSOPRAZOLE FDT02392402Approved
MYLAN-LANSOPRAZOLE FDT02392410Approved
MYLAN-VERAPAMIL SR02450461Approved
MYLAN-VERAPAMIL SR02450488Dormant
MYLAN-VERAPAMIL SR02450496Dormant
QUATERNA02426927Approved
SUGAMMADEX INJECTION02542374Approved
ACID REDUCER02237829Cancelled Post Market
ACID REDUCER MAXIMUM STRENGTH NON-PRESCRIPTION02303221Cancelled Pre Market
ADENOSINE INJECTION, USP02401061Cancelled Pre Market
ADENOSINE INJECTION, USP02409585Cancelled Pre Market
AMIODARONE HYDROCHLORIDE INJECTION02387700Cancelled Pre Market
AMIODARONE HYDROCHLORIDE INJECTION02388049Cancelled Post Market
AMPICILLIN SODIUM FOR INJECTION, BP02445093Cancelled Pre Market
AMPICILLIN SODIUM FOR INJECTION, BP02445107Cancelled Pre Market
AMPICILLIN SODIUM FOR INJECTION, BP02445115Cancelled Pre Market
AMPICILLIN SODIUM FOR INJECTION, BP02445123Cancelled Pre Market
AZITHROMYCIN FOR INJECTION, USP02385473Cancelled Post Market
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION02498103Cancelled Post Market
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION02498111Cancelled Post Market
BUPIVACAINE HYDROCHLORIDE INJECTION USP02430886Cancelled Pre Market
BUPIVACAINE HYDROCHLORIDE INJECTION USP02430894Cancelled Pre Market
BUPIVACAINE HYDROCHLORIDE INJECTION USP02430908Cancelled Pre Market
BUPIVACAINE HYDROCHLORIDE INJECTION USP02430916Cancelled Pre Market
BUPIVACAINE HYDROCHLORIDE INJECTION USP02430924Cancelled Pre Market
CARBACHOL02060043Cancelled Post Market
CEPORACIN02060051Cancelled Post Market
CHLORPROMAZINE HCL INJ 25MG/ML USP01933272Cancelled Post Market
CISATRACURIUM BESYLATE INJECTION02406519Cancelled Pre Market
CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE-FREE)02406527Cancelled Pre Market
CISPLATIN INJECTION, MYLAN STD.02396890Cancelled Post Market
CITALOPRAM02284847Cancelled Post Market
CITALOPRAM02284855Cancelled Post Market
CLINDAMYCIN INJECTION, USP02440091Cancelled Pre Market
CRYSTAPEN02060094Cancelled Post Market
CYTARABINE INJECTION, MYLAN STD.02402203Cancelled Pre Market
DIMENHYDRINATE INJECTION, USP02061732Cancelled Pre Market
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS02425726Cancelled Pre Market
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 2102424452Cancelled Pre Market
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 2802424460Cancelled Pre Market
EPHEDRINE SULPHATE INJECTION, USP02242961Cancelled Post Market
EPINEPHRINE INJECTION USP02063204Cancelled Pre Market
ERGONOVINE MALEATE INJECTION01996096Cancelled Pre Market
ESME 2102388138Cancelled Post Market
ESME 2802388146Cancelled Post Market
FAMOTIDINE INJECTION02383071Cancelled Pre Market
FAMOTIDINE INJECTION02383098Cancelled Pre Market
FLUDARABINE PHOSPHATE INJECTION02406381Cancelled Pre Market
FLUMAZENIL INJECTION, USP02430169Cancelled Pre Market
FLUPHENAZINE DECANOATE INJECTION, USP02383225Cancelled Pre Market
FULVESTRANT INJECTION02468549Cancelled Post Market
GEMCITABINE FOR INJECTION, USP02407299Cancelled Pre Market
GEMCITABINE FOR INJECTION, USP02407302Cancelled Post Market
GEMCITABINE FOR INJECTION, USP02407310Cancelled Post Market
GEN-CLOZAPINE02421097Cancelled Pre Market
IDARUBICIN HYDROCHLORIDE INJECTION02410354Cancelled Pre Market
LABETALOL HYDROCHLORIDE INJECTION, USP02387468Cancelled Post Market
LIDOCAINE AND EPINEPHRINE INJ.USP 2% 1:10000002062151Cancelled Pre Market
LIDOCAINE HYDROCHLORIDE INJECTION USP01947060Cancelled Pre Market
LIDOCAINE HYDROCHLORIDE INJECTION USP02067021Cancelled Pre Market
LORATADINE02284669Cancelled Pre Market
METFORMIN02284782Cancelled Post Market
METFORMIN02284790Cancelled Post Market
METHYLENE BLUE INJECTION, USP02094665Cancelled Pre Market
MIDAZOLAM INJECTION02383586Cancelled Pre Market
MIDAZOLAM INJECTION02383594Cancelled Pre Market
MYL-DIVALPROEX02265133Cancelled Post Market
MYL-DIVALPROEX02265141Cancelled Post Market
MYL-DIVALPROEX02265168Cancelled Post Market
MYL-LETROZOLE02372169Cancelled Post Market
MYL-PREGABALIN02408651Cancelled Post Market
MYL-PREGABALIN02408678Cancelled Post Market
MYL-PREGABALIN02408686Cancelled Post Market
MYL-PREGABALIN02408694Cancelled Post Market
MYL-PREGABALIN02408708Cancelled Post Market
MYL-PREGABALIN02408716Cancelled Pre Market
MYL-PROPAFENONE02245372Cancelled Post Market
MYL-PROPAFENONE02245373Cancelled Post Market
MYL-RANITIDINE02367378Cancelled Post Market
MYL-RANITIDINE02367386Cancelled Post Market
MYL-SILDENAFIL02392577Cancelled Post Market
MYL-SILDENAFIL02392585Cancelled Post Market
MYL-SILDENAFIL02392593Cancelled Post Market
MYLAN-ACEBUTOLOL02237721Cancelled Post Market
MYLAN-ACEBUTOLOL02237722Cancelled Post Market
MYLAN-ACEBUTOLOL02237723Cancelled Post Market
MYLAN-ACEBUTOLOL (TYPE S)02237885Cancelled Post Market
MYLAN-ACEBUTOLOL (TYPE S)02237886Cancelled Post Market
MYLAN-ACEBUTOLOL (TYPE S)02237887Cancelled Post Market
MYLAN-ALENDRONATE02270129Cancelled Post Market
MYLAN-ALENDRONATE02286335Cancelled Post Market
MYLAN-ALPRAZOLAM02137534Cancelled Post Market
MYLAN-ALPRAZOLAM02137542Cancelled Post Market
MYLAN-ALPRAZOLAM02229813Cancelled Post Market
MYLAN-ALPRAZOLAM02229814Cancelled Post Market
MYLAN-AMANTADINE02139200Cancelled Post Market
MYLAN-AMILAZIDE02257378Cancelled Post Market
MYLAN-AMIODARONE02240604Cancelled Post Market
MYLAN-AMLODIPINE/ATORVASTATIN02400758Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400774Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400782Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400790Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400804Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400812Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400820Cancelled Pre Market
MYLAN-AMLODIPINE/ATORVASTATIN02400839Cancelled Pre Market
MYLAN-AMOXICILLIN02238171Cancelled Post Market
MYLAN-AMOXICILLIN02238172Cancelled Post Market
MYLAN-ANAGRELIDE02253054Cancelled Post Market
MYLAN-ANASTROZOLE02361418Cancelled Post Market
MYLAN-ATENOLOL02146894Cancelled Post Market
MYLAN-ATENOLOL02147432Cancelled Post Market
MYLAN-ATENOLOL02303647Cancelled Post Market
MYLAN-ATOMOXETINE02378930Cancelled Post Market
MYLAN-ATOMOXETINE02378949Cancelled Post Market
MYLAN-ATOMOXETINE02378957Cancelled Post Market
MYLAN-ATOMOXETINE02378965Cancelled Post Market
MYLAN-ATOMOXETINE02378973Cancelled Post Market
MYLAN-ATOMOXETINE02378981Cancelled Post Market
MYLAN-ATORVASTATIN02373203Cancelled Post Market
MYLAN-ATORVASTATIN02373211Cancelled Post Market
MYLAN-ATORVASTATIN02373238Cancelled Post Market
MYLAN-ATORVASTATIN02373246Cancelled Post Market
MYLAN-AZATHIOPRINE02231491Cancelled Post Market
MYLAN-AZITHROMYCIN02278359Cancelled Post Market
MYLAN-BICALUTAMIDE02302403Cancelled Post Market
MYLAN-BISOPROLOL02384418Cancelled Post Market
MYLAN-BISOPROLOL02384426Cancelled Post Market
MYLAN-BOSENTAN02383497Cancelled Post Market
MYLAN-BOSENTAN02383500Cancelled Post Market
MYLAN-BROMAZEPAM02192705Cancelled Post Market
MYLAN-BUPRENORPHINE/NALOXONE02408090Cancelled Post Market
MYLAN-BUPRENORPHINE/NALOXONE02408104Cancelled Post Market
MYLAN-BUPROPION XL02382075Cancelled Post Market
MYLAN-BUPROPION XL02382083Cancelled Post Market
MYLAN-BUSPIRONE02230874Cancelled Post Market
MYLAN-CANDESARTAN02379120Cancelled Post Market
MYLAN-CANDESARTAN02379139Cancelled Post Market
MYLAN-CANDESARTAN02379147Cancelled Post Market
MYLAN-CANDESARTAN02379155Cancelled Post Market
MYLAN-CANDESARTAN HCTZ02374897Cancelled Post Market
MYLAN-CANDESARTAN HCTZ02423324Cancelled Pre Market
MYLAN-CANDESARTAN HCTZ02423332Cancelled Pre Market
MYLAN-CAPTOPRIL02163586Cancelled Post Market
MYLAN-CAPTOPRIL02163594Cancelled Post Market
MYLAN-CAPTOPRIL02163578Cancelled Post Market
MYLAN-CAPTOPRIL02163551Cancelled Post Market
MYLAN-CARBAMAZEPINE CR02241882Cancelled Post Market
MYLAN-CARBAMAZEPINE CR02241883Cancelled Post Market
MYLAN-CARVEDILOL02347512Cancelled Post Market
MYLAN-CARVEDILOL02347520Cancelled Post Market
MYLAN-CARVEDILOL02347555Cancelled Post Market
MYLAN-CARVEDILOL02347571Cancelled Post Market
MYLAN-CELECOXIB02399881Cancelled Post Market
MYLAN-CELECOXIB02423278Cancelled Post Market
MYLAN-CIMETIDINE02227444Cancelled Post Market
MYLAN-CIMETIDINE02227452Cancelled Post Market
MYLAN-CIMETIDINE02227460Cancelled Post Market
MYLAN-CIMETIDINE02227479Cancelled Post Market
MYLAN-CIPROFLOXACIN02245647Cancelled Post Market
MYLAN-CIPROFLOXACIN02245648Cancelled Post Market
MYLAN-CIPROFLOXACIN02245649Cancelled Post Market
MYLAN-CIPROFLOXACIN XL02416476Cancelled Pre Market
MYLAN-CIPROFLOXACIN XL02416484Cancelled Pre Market
MYLAN-CITALOPRAM02246593Cancelled Pre Market
MYLAN-CITALOPRAM02246594Cancelled Post Market
MYLAN-CITALOPRAM02246595Cancelled Post Market
MYLAN-CLARITHROMYCIN02248856Cancelled Post Market
MYLAN-CLARITHROMYCIN02248857Cancelled Post Market
MYLAN-CLINDAMYCIN02258331Cancelled Post Market
MYLAN-CLINDAMYCIN02258358Cancelled Post Market
MYLAN-CLONAZEPAM02230950Cancelled Post Market

Showing 300 of 608 drug products. For the rest, search Health Canada’s database.

Notices of Compliance

Newest first.

  • MYLAN-DIVALPROEXAugust 4, 2026 · NOC 38090 · Supplement to a New Drug Submission (SNDS)
  • VTRS-ELETRIPTANJuly 16, 2026 · NOC 37926 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-VALACYCLOVIRJuly 13, 2026 · NOC 37908 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-PANTOPRAZOLE TMay 26, 2026 · NOC 37617 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-SUMATRIPTANMay 7, 2026 · NOC 37493 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • WIXELA INHUBApril 1, 2026 · NOC 37253 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-HYDROXYUREAMarch 17, 2026 · NOC 37118 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • GEN-CLOZAPINEMarch 9, 2026 · NOC 37069 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-DIVALPROEXFebruary 20, 2026 · NOC 36939 · Supplement to a New Drug Submission (SNDS)
  • SUGAMMADEX INJECTIONFebruary 9, 2026 · NOC 36911 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • CLARUSJanuary 6, 2026 · NOC 36686 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-AMLODIPINE/ATORVASTATINJanuary 2, 2026 · NOC 36663 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-TOPIRAMATEDecember 12, 2025 · NOC 36559 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-AMLODIPINE/ATORVASTATINDecember 9, 2025 · NOC 36498 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-LAMOTRIGINEOctober 31, 2025 · NOC 36340 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ATORVASTATINOctober 27, 2025 · NOC 36287 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • GLATIRAMER ACETATE INJECTIONOctober 16, 2025 · NOC 36223 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-FINGOLIMODSeptember 11, 2025 · NOC 36008 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ATAZANAVIRJuly 17, 2025 · NOC 35713 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • CONTINGENCY ONEJune 30, 2025 · NOC 35605 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-MIRTAZAPINEMarch 21, 2025 · NOC 35048 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-HYDROXYUREAMarch 7, 2025 · NOC 34973 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • GEN-CLOZAPINEMarch 4, 2025 · NOC 34943 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-AZELASTINE/FLUTICASONEMarch 3, 2025 · NOC 34939 · Supplement to a New Drug Submission (SNDS)
  • FREYA 21; FREYA 28February 21, 2025 · NOC 34884 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • GEN-CLOZAPINEJanuary 24, 2025 · NOC 34744 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-ESCITALOPRAMDecember 31, 2024 · NOC 34620 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ONDANSETRONNovember 15, 2024 · NOC 34384 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-LATANOPROSTNovember 15, 2024 · NOC 34393 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-GALANTAMINE ERNovember 8, 2024 · NOC 34348 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • WIXELA INHUBNovember 5, 2024 · NOC 34330 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-LAMOTRIGINEOctober 22, 2024 · NOC 34273 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-INDAPAMIDEOctober 8, 2024 · NOC 34162 · Supplement to a New Drug Submission (SNDS)
  • QUATERNASeptember 19, 2024 · NOC 34049 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • INDAYOSeptember 12, 2024 · NOC 34005 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-EFAVIRENZAugust 29, 2024 · NOC 33901 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SUGAMMADEX INJECTIONAugust 6, 2024 · NOC 33759 · Abbreviated New Drug Submission (ANDS)
  • MYLAN-FLUCONAZOLEAugust 1, 2024 · NOC 33749 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-GALANTAMINE ERJune 4, 2024 · NOC 33389 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-VALACYCLOVIRMay 16, 2024 · NOC 33234 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ATAZANAVIRApril 18, 2024 · NOC 33074 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-RIVASTIGMINE PATCH 10; MYLAN-RIVASTIGMINE PATCH 5April 8, 2024 · NOC 33023 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-CILAZAPRILMarch 20, 2024 · NOC 32922 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-RILUZOLEMarch 19, 2024 · NOC 32916 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-DIVALPROEXMarch 14, 2024 · NOC 32875 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-GLICLAZIDE MRMarch 8, 2024 · NOC 32842 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-ESCITALOPRAMFebruary 23, 2024 · NOC 32774 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-NIFEDIPINE EXTENDED RELEASEJanuary 24, 2024 · NOC 32594 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ATAZANAVIRJanuary 13, 2024 · NOC 34681 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ELETRIPTANDecember 5, 2023 · NOC 32293 · New Drug Submission (NDS)
  • MYLAN-SUMATRIPTANDecember 1, 2023 · NOC 32249 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-TOPIRAMATEDecember 1, 2023 · NOC 32271 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-AMLODIPINE/ATORVASTATINNovember 28, 2023 · NOC 32193 · New Drug Submission (NDS)
  • MYLAN-AMLODIPINENovember 22, 2023 · NOC 32164 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-LATANOPROSTNovember 16, 2023 · NOC 32114 · New Drug Submission (NDS)
  • MYLAN-LATANOPROST/TIMOLOLNovember 16, 2023 · NOC 32115 · New Drug Submission (NDS)
  • MYLAN-ATORVASTATINOctober 25, 2023 · NOC 31934 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-LANSOPRAZOLE; MYLAN-LANSOPRAZOLE FDTOctober 11, 2023 · NOC 31822 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-PANTOPRAZOLE TOctober 6, 2023 · NOC 31791 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-VALACYCLOVIROctober 6, 2023 · NOC 31806 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ABACAVIR/LAMIVUDINESeptember 29, 2023 · NOC 31753 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • GLATIRAMER ACETATE INJECTIONSeptember 13, 2023 · NOC 31619 · Abbreviated New Drug Submission (ANDS)
  • MYLAN-ESCITALOPRAMAugust 25, 2023 · NOC 31522 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • FREYA 21; FREYA 28August 2, 2023 · NOC 31356 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-LAMOTRIGINEJuly 25, 2023 · NOC 31294 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-NAPROXEN/ESOMEPRAZOLE MRJuly 21, 2023 · NOC 31280 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • BENDAMUSTINE HYDROCHLORIDE FOR INJECTIONJuly 21, 2023 · NOC 31295 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • QUATERNAJuly 14, 2023 · NOC 31233 · Abbreviated New Drug Submission (ANDS)
  • MYL-ESOMEPRAZOLEJuly 13, 2023 · NOC 31203 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • QUATERNAJuly 7, 2023 · NOC 31185 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-FLUCONAZOLEMay 25, 2023 · NOC 30835 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ZIPRASIDONEMay 3, 2023 · NOC 30629 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21; DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28April 17, 2023 · NOC 30615 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-HYDROXYUREAApril 5, 2023 · NOC 30479 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-FINGOLIMODMarch 30, 2023 · NOC 30423 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-TOPIRAMATEMarch 28, 2023 · NOC 30469 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-LANSOPRAZOLE; MYLAN-LANSOPRAZOLE FDTJanuary 19, 2023 · NOC 29931 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • BENDAMUSTINE HYDROCHLORIDE FOR INJECTIONDecember 8, 2022 · NOC 29649 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-MIRTAZAPINEOctober 28, 2022 · NOC 29343 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ONDANSETRONSeptember 15, 2022 · NOC 28978 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-AZELASTINE/FLUTICASONESeptember 1, 2022 · NOC 28871 · New Drug Submission (NDS)
  • MYLAN-PERINDOPRIL/INDAPAMIDEAugust 24, 2022 · NOC 28816 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MOVISSEAugust 16, 2022 · NOC 28770 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • GEN-CLOZAPINEJuly 29, 2022 · NOC 28677 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-VERAPAMIL SRJune 13, 2022 · NOC 28389 · New Drug Submission (NDS)
  • MYLAN-DIVALPROEXMay 4, 2022 · NOC 28083 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATEApril 13, 2022 · NOC 27963 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-PROPAFENONEApril 12, 2022 · NOC 27973 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-TOPIRAMATEFebruary 18, 2022 · NOC 27628 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-CILAZAPRILDecember 8, 2021 · NOC 27204 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • INDAYOAugust 20, 2021 · NOC 26488 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • PACLITAXEL INJECTION, USPAugust 16, 2021 · NOC 26451 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-FINGOLIMODJuly 7, 2021 · NOC 26232 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-PANTOPRAZOLE TJune 28, 2021 · NOC 26142 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-ATAZANAVIRJune 10, 2021 · NOC 26049 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-BACLOFENMay 14, 2021 · NOC 25871 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-INDAPAMIDEMay 14, 2021 · NOC 25880 · Supplement to a New Drug Submission (SNDS)
  • MYLAN-TOPIRAMATEApril 16, 2021 · NOC 25688 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-FLUCONAZOLEApril 15, 2021 · NOC 25687 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • MYLAN-PROPAFENONEMarch 12, 2021 · NOC 25444 · Supplement to a New Drug Submission (SNDS)

The latest 100 of 536.

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.